Reviews
Summary
Positives
- A Long COVID patient who experimented with iboga minidoses said the practice helped her start exercising regularly again, even though she made clear it was not a panacea LDN Research Trust.
Negatives
- No published Long COVID-specific clinical evidence for ibogaine yet exists, leaving patients to rely entirely on anecdotal reports from social networks and online forums when deciding whether to try it LDN Research Trust.
Hurdles & Side Effects
- Ibogaine carries a documented risk of QT-interval prolongation and cardiac arrhythmias, and several deaths have been reported during unsupervised use, which is why most credible providers screen for cardiac history and monitor with continuous ECG Frontiers in Pain Research.
- Ibogaine is illegal in the United States (Schedule I) and most patient experience comes from clinics in Mexico, Costa Rica, or Portugal, with retreats typically costing $5,000-$15,000 plus travel Experience Ibogaine.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care